KeyBank National Association’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,039
Closed -$121K 954
2018
Q3
$121K Sell
4,039
-2,462
-38% -$110K ﹤0.01% 1029
2018
Q2
$286K Buy
+6,501
New +$241K ﹤0.01% 892

Other funds holding COCP

KeyBank National Association's COCP Position: Q4 2018 in Review

KeyBank National Association sold out of Cocrystal Pharma (COCP) in Q4 2018, closing a stake of 4,039 shares — an estimated $121K sold.

KeyBank National Association first reported a position in COCP in Q2 2018 and held it in 2 quarters. The position peaked at $286K in Q2 2018. 19 funds tracked by Wall St. Rank hold COCP as of Q4 2018.

  • KeyBank National Association reported no remaining Cocrystal Pharma position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 4,039 Cocrystal Pharma shares in Q4 2018, an estimated $121K.
  • KeyBank National Association first reported a position in Cocrystal Pharma in Q2 2018 and held it in 2 quarters.
  • KeyBank National Association's Cocrystal Pharma position peaked at $286K in Q2 2018.
  • 19 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.